These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 533261)

  • 1. Antibacterial activities, nephrotoxicity, and ototoxicity of a new aminoglycoside, Win 42122-2.
    Came PE; O'Connor JR; Dobson RA; Wagner RB; Fabian RJ
    Antimicrob Agents Chemother; 1979 Dec; 16(6):813-22. PubMed ID: 533261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dactimicin, a new, less toxic aminoglycoside antibiotic active against resistant bacteria.
    Omoto S; Yoshida T; Kurebe M; Inouye S
    Drugs Exp Clin Res; 1987; 13(12):719-25. PubMed ID: 3447874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro studies with Win 42122-2: comparison with gentamicin, netilmicin, and amikacin.
    Sanders CC; Sanders WE
    Antimicrob Agents Chemother; 1981 Aug; 20(2):247-51. PubMed ID: 7283421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics.
    Kabins SA; Nathan C; Cohen S
    Antimicrob Agents Chemother; 1976 Jul; 10(1):139-45. PubMed ID: 825021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-N HAPA gentamicin B, a new aminoglycoside active against gentamicin resistant isolates--activity compared to other aminoglycosides.
    Neu HC; Fu KP
    J Antibiot (Tokyo); 1978 May; 31(5):385-93. PubMed ID: 27494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
    Drasar FA; Farrell W; Maskell J; Williams JD
    Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new aminoglycoside etimicin shows low nephrotoxicity and ototoxicity in zebrafish embryos.
    Shao W; Zhong D; Jiang H; Han Y; Yin Y; Li R; Qian X; Chen D; Jing L
    J Appl Toxicol; 2021 Jul; 41(7):1063-1075. PubMed ID: 33094525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.
    Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
    Drugs; 1976; 12(3):166-200. PubMed ID: 789045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C; Kauffman CA
    Infection; 1978; 6(3):111-5. PubMed ID: 98451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo antimicrobial activities of sporaricin A, a new aminoglycoside.
    Kobayashi F; Saino Y; Koshi T; Hattori Y
    Antimicrob Agents Chemother; 1980 Mar; 17(3):337-43. PubMed ID: 7425599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L; Robinson RG; Koornhof HJ
    S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gentamicin-induced ototoxicity and nephrotoxicity vary with circadian time of treatment and entail separate mechanisms.
    Blunston MA; Yonovitz A; Woodahl EL; Smolensky MH
    Chronobiol Int; 2015; 32(9):1223-32. PubMed ID: 26506922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.
    Reynolds AV; Hamilton-Miller JM; Brumfitt W
    Br Med J; 1974 Sep; 3(5934):778-80. PubMed ID: 4213265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic.
    Miller GH; Arcieri G; Weinstein MJ; Waitz JA
    Antimicrob Agents Chemother; 1976 Nov; 10(5):827-36. PubMed ID: 1008541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms.
    Rahal JJ; Simberkoff MS; Kagan K; Moldover NH
    Antimicrob Agents Chemother; 1976 Apr; 9(4):595-9. PubMed ID: 817661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vivo acquisition of two different types of aminoglycoside resistance by a single strain of Klebsiella pneumoniae causing severe infection.
    Murray BE; Moellering RC
    Ann Intern Med; 1982 Feb; 96(2):176-80. PubMed ID: 7036812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.
    Zhanel GG; Lawson CD; Zelenitsky S; Findlay B; Schweizer F; Adam H; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Expert Rev Anti Infect Ther; 2012 Apr; 10(4):459-73. PubMed ID: 22512755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of netilmicin, gentamicin, and amikacin.
    Kantor RJ; Norden CW
    Antimicrob Agents Chemother; 1977 Jan; 11(1):126-31. PubMed ID: 402104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glucarolactam on ototoxicity of aminoglycoside antibiotics in guinea-pigs.
    Yokota M; Niizato T; Inouye S; Kitasato I
    Drugs Exp Clin Res; 1989; 15(6-7):261-72. PubMed ID: 2591298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.